Best Agrolife net profit surges 104% in Q1FY27 on margin expansion
Best Agrolife's Q1FY27 results show a 104% surge in net profit to ₹41 crore, fueled by an 8 percentage point expansion in EBITDA margin to 20%. Revenue grew 4% to ₹396 crore as patented products gained traction despite uneven rainfall affecting Kharif sowing.
*this image is generated using AI for illustrative purposes only.
Best Agrolife Limited Best Agrolife Limited reported a consolidated net profit after tax (PAT) of ₹41 crore for the quarter ended June 30, 2026 (Q1FY27), marking a 104% year-on-year increase from ₹20 crore in Q1FY26. The agrochemical manufacturer achieved this significant profitability improvement despite uneven rainfall patterns delaying Kharif sowing, leveraging operational efficiencies, favourable product mix, and price increases to expand its EBITDA margin to 20% from 12% in the prior year period. The strong bottom-line performance underscores the company's strategic shift towards margin optimization rather than volume-driven expansion, offering resilience against seasonal agricultural headwinds.
The Board of Directors approved the unaudited financial results on July 30, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by M/s Walker Chandiok & Co LLP, the statutory auditors of the company. Consolidated revenue from operations rose 4% YoY to ₹396 crore from ₹381 crore in Q1FY26. Standalone revenue grew 4% to ₹262.07 crore from ₹313.49 crore, reflecting specific segment performance within the group structure.
Financial Performance Highlights
| Metric | Q1FY27 Consolidated | Q1FY26 Consolidated | YoY Change | Q4FY26 Consolidated | QoQ Change |
|---|---|---|---|---|---|
| Revenue from Operations (₹ crore) | 396.20 | 381.24 | 4% | 155.69 | 154% |
| Gross Margin % | 37% | 29% | 8% pp | 23% | 14% pp |
| EBITDA (₹ crore) | 78.00 | 46.00 | 70% | (27.00) | 388% |
| EBITDA Margin % | 20% | 12% | 8% pp | (17)% | 37% pp |
| Net Profit After Tax (₹ crore) | 40.65 | 19.92 | 104% | (37.24) | 209% |
Consolidated gross profit increased 32% YoY to ₹146 crore, with the gross margin improving to 37% from 29% in the prior year quarter. Operating expenses, including finance costs and depreciation, increased by 4% to ₹92.97 crore. Inventory levels stood at ₹764 crore as of June 30, 2026, marking a 6% reduction from ₹812 crore a year ago, indicating improved working capital efficiency. The PAT margin increased to 10%, up from 5% in Q1FY26.
Operational Context and Market Dynamics
Vimal Kumar, Managing Director of Best Agrolife Limited, attributed the strong financial performance to the strength of the company’s differentiated product portfolio. Key products including Bestman, Fetagen, Warden Extra, and Ronfen continued to gain market acceptance, while newly launched patented products Fluzam and Cubax Power Extra saw increasing adoption. The volume of patented products increased by 37%, contributing significantly to the margin expansion. However, irregular rainfall patterns affected demand for seed treatment products, and lower spray applications in vegetables, early-sown groundnut, chilli, and cotton impacted crop protection demand in certain regions.
Regulatory Disclosures and Tax Proceedings
The auditor’s review report highlighted ongoing proceedings related to a search and seizure operation conducted by the Income Tax Department between September 26 and September 30, 2023, under Section 132 of the Income Tax Act, 1961. The operation targeted the head office, two wholly-owned subsidiaries, and residences of certain Key Managerial Persons.
While the holding company received favourable orders for Assessment Years (AY) 2022-23 and 2024-25, it faced a demand order of ₹0.95 crore for AY 2021-22 regarding disallowance of expenses, against which a rectification request was filed. Subsidiary Best Crop Science Private Limited received a demand order of ₹6 crore for AY 2023-24, which was appealed to the Income Tax Appellate Tribunal after dismissal by the Commissioner of Income Tax (Appeals). Reassessment notices have been received for AY 2018-19 to AY 2020-21 for the holding company and earlier years for subsidiaries, with final outcomes yet to be determined. Management has not identified the need for adjustments in the current quarter’s results based on available information.
What the Numbers Show
The divergence between modest revenue growth (4%) and substantial profit growth (104%) underscores a strategic shift towards margin optimization rather than volume-driven expansion. The expansion in EBITDA margin by 8 percentage points, coupled with a 32% jump in gross profit, indicates that price increases and cost management measures are outpacing input cost inflation. This margin leverage suggests that even in a challenging demand environment caused by monsoon delays, Best Agrolife is successfully protecting its bottom line through product mix optimization and operational discipline. The contribution of patented products in branded sales rose to 64% from 45% in Q1FY26, highlighting the success of its innovation strategy.
Historical Stock Returns for Best Agrolife
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.84% | +9.28% | +12.09% | -16.58% | -46.28% | -53.49% |
How might the resolution of the ₹6 crore tax demand against Best Crop Science and ongoing reassessment notices impact Best Agrolife's future cash flows and net profit margins?
Given the 37% volume growth in patented products, what is the company's roadmap for sustaining this innovation-led margin expansion as competitors attempt to replicate or challenge these formulations?
Will the current strategy of prioritizing price increases and margin optimization over volume growth remain sustainable if Kharif sowing delays persist or worsen in subsequent quarters?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
